Kass, M A <br/><br/>
Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.  [electronic resource] 

 -  Transactions of the American Ophthalmological Society  1989 
 - 598-618 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0065-9533 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Demography<br/>Double-Blind Method<br/>Female<br/>Glaucoma--physiopathology<br/>Humans<br/>Intraocular Pressure--drug effects<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Ocular Hypertension--drug therapy<br/>Optic Disk--physiopathology<br/>Timolol--therapeutic use<br/>Visual Fields--drug effects